Coronary Angiography (CAG), Coronary Artery Bypass Grafting, Coronary Artery Disease, Coronary Computed Tomography Angiography
Conditions
Keywords
Major Adverse Cardiovascular Events (MACE), Coronary Artery Bypass Grafting (CABG), Coronary Computed Tomography Angiography(CCTA), Coronary Angiography(CAG)
Brief summary
The goal of this clinical trial is to find out if using a non-invasive heart scan (called coronary computed tomography angiography, or CCTA) to plan coronary artery bypass grafting (CABG) works as well as the standard invasive approach (called coronary angiography, or CAG) for people with blocked heart arteries. The main questions it aims to answer are: Do people who have surgery planned with the non-invasive heart scan have similar health outcomes at 1 year as those who have surgery planned with the standard invasive approach? How does the non-invasive approach compare in terms of heart attacks, strokes, unplanned repeat procedures, and longer hospital stays? Researchers will compare two groups of participants. One group will have their surgery planned using only the CCTA . The other group will have their surgery planned using only the CAG. Both groups will undergo the CABG per local protocol. Participants will: Be randomly assigned (like flipping a coin) to one of the two planning approaches Undergo CABG as scheduled Return for follow-up visits at sugery days, 7 days, 1 month, 6 months, and 1 year after surgery Have a follow-up CCTA scan at 7 days and 1 year to check if the new bypass grafts are working well
Interventions
PROCEDURECCTA-based CABG
Surgical planning based solely on CCTA-derived data, including diameter stenosis (DS), area stenosis (AS), CT-derived fractional flow reserve (CT-FFR), LV:RV perfusion index, plaque characterization, 3D reconstruction of target vessels, and collateral circulation of chronic total occlusions (CTO) and so on. CCTA performed using photon-counting CT or conventional CT (≥64-slice, preferably ≥256-slice), following a standardized acquisition protocol. Images are transferred to an independent core laboratory for quantitative analysis and standardized reporting. The operating surgeon will not have access to CAG.
PROCEDURECAG-based CABG
Surgical planning following standard practice using invasive coronary angiography(CAG). Angiograms obtained using a flat-panel detector system with standardized projections. The results of CAG are interpreted by the operating surgeon.The operating surgeon will not have access to CCTA.
Sponsors
Ruijin Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Referred to CABG treatment
Exclusion criteria
* Under the age of 18 years * Unable to provide informed consent * Emergency CABG * Redo-CABG * Prior PCI with coronary stent implantation * Cardiogenic shock * Unable to undergo CAG or CCTA examination or deemed unsuitable by the investigator, such as: Known allergy to iodinated contrast media; Active hyperthyroidism or uncontrolled thyroid disease; Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m²; Atrial fibrillation with rapid ventricular response or severe arrhythmias not amenable to rate control; * Pregnancy, lactation, or childbearing potential without effective contraception in female participants * Concurrent participation in another interventional trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 1-year incidence of 5-Point Major Adverse Cardiovascular Events (5P-MACE) | Within 1 year post-CABG | The 5P-MACE was defined as a composite of all-cause death, myocardial infarction, stroke, unplanned revascularization, and CABG-related or cardiovascular-related prolonged postoperative length of stay (PLOS) or rehospitalization. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 1-year incidence of all-cause death | Within 1 year post-CABG | — |
| 1-year incidence of CV death | within 1 year post-CABG | — |
| 1-year incidence of MI | Within 1 year post-CABG | — |
| 1-year incidence of stroke | Within 1 year post-CABG | — |
| 1-year incidence of unplanned revascularization | Within 1 year post-CABG | — |
| 1-year incidence of CABG-related or CV-related prolonged PLOS or rehospitalization. | Within 1 year post-CABG | — |
| 30-day incidence of the operative mortality and morbidity | Within 30 days post-CABG | The operative mortality and morbidity was defined as a composite of all-cause death, myocardial infarction, stroke, unplanned revascularization, cardiac arrest, reoperation, prolonged ventilation, deep sternal wound infection, pacemaker implantation, major gastrointestinal bleeding, and new dialysis . |
| 7-day graft failure rate | At 7 day post-CABG | Graft failure defined as modified FitzGibbon grade B, S, or O, assessed by CCTA. |
| 1-year graft failure rate | At 1 year post-CABG | Graft failure defined as modified FitzGibbon grade B, S, or O, assessed by CCTA. |
| Other serious adverse events (SAE) | Within 1 year post-CABG | Important medical events that impact subjects' daily life or health and require appropriate intervention, but are not part of the primary or secondary outcome definitions above |
Countries
China
Contacts
CONTACTYunpeng Zhu, MD
Outcome results
None listed